PMID- 24151629 OWN - NLM STAT- MEDLINE DCOM- 20140602 LR - 20211021 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2013 DP - 2013 TI - Anti-inflammatory activity of bioaccessible fraction from Eryngium foetidum leaves. PG - 958567 LID - 10.1155/2013/958567 [doi] LID - 958567 AB - Eryngium foetidum (EF) has long been used as a medicinal plant and culinary spice in tropical regions. Phytochemicals in its leaves have been proposed to be responsible for the anti-inflammatory and antioxidant activities. The present study used in vitro digestion coupled with Caco-2 cells to assess such activities. Caco-2 cells were incubated with aqueous fraction from simulated digestion (bioaccessible fraction) of EF leaves with/without bile extract prior to stimulation with interleukin-1 beta (IL-1beta). Monocyte chemoattractant protein-1 (MCP-1) and IL-8 in culture media and the intracellular reactive oxygen species (ROS) were measured. Approximately 24% beta-carotene and 35% lutein of leaves were present in the aqueous fraction. The transfer of caffeic and chlorogenic acids to the aqueous fraction was 76%-81%, while that of kaempferol was 48%. Prior incubation of Caco-2 cells with the bioaccessible fraction suppressed IL-1beta activated IL-8 and MCP-1 by 33%, but the fraction lacking mixed micelles decreased IL-8 and MCP-1 levels only by 11%. The pretreatment of Caco-2 cells with the bioaccessible fraction of EF reduced ROS by 34%; the fraction lacking mixed micelles decreased ROS by 28%. These data suggest that bioactive compounds partitioning in mixed micelles play a significant role to suppress the proinflammatory insult but with a modest antioxidant effect. FAU - Dawilai, Suwitcha AU - Dawilai S AD - Institute of Nutrition, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand. FAU - Muangnoi, Chawanphat AU - Muangnoi C FAU - Praengamthanachoti, Phawachaya AU - Praengamthanachoti P FAU - Tuntipopipat, Siriporn AU - Tuntipopipat S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130917 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antioxidants) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-8) RN - 0 (Plant Extracts) RN - 0 (Reactive Oxygen Species) RN - 01YAE03M7J (beta Carotene) RN - X72A60C9MT (Lutein) SB - IM MH - Anti-Inflammatory Agents/pharmacology MH - Antioxidants/pharmacology MH - Caco-2 Cells MH - Chemokine CCL2/biosynthesis MH - Eryngium/*chemistry MH - Gene Expression Regulation/*drug effects MH - Humans MH - Inflammation/*drug therapy/pathology MH - Interleukin-1beta/biosynthesis MH - Interleukin-8/biosynthesis MH - Lutein/chemistry/isolation & purification MH - Plant Extracts/chemistry/*pharmacology MH - Plant Leaves/chemistry MH - Reactive Oxygen Species/metabolism MH - beta Carotene/chemistry/isolation & purification PMC - PMC3789289 EDAT- 2013/10/24 06:00 MHDA- 2014/06/03 06:00 PMCR- 2013/09/17 CRDT- 2013/10/24 06:00 PHST- 2013/04/30 00:00 [received] PHST- 2013/07/29 00:00 [revised] PHST- 2013/08/01 00:00 [accepted] PHST- 2013/10/24 06:00 [entrez] PHST- 2013/10/24 06:00 [pubmed] PHST- 2014/06/03 06:00 [medline] PHST- 2013/09/17 00:00 [pmc-release] AID - 10.1155/2013/958567 [doi] PST - ppublish SO - Biomed Res Int. 2013;2013:958567. doi: 10.1155/2013/958567. Epub 2013 Sep 17.